Andrew C. Weiss
Investor Relations Contact bei IDORSIA LTD
Aktive Positionen von Andrew C. Weiss
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IDORSIA LTD | Investor Relations Contact | 01.06.2017 | - |
| Public Communications Contact | 01.06.2017 | - |
Karriereverlauf von Andrew C. Weiss
Ehemalige bekannte Positionen von Andrew C. Weiss
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ACTELION | Investor Relations Contact | 05.05.2014 | 01.01.2017 |
| Public Communications Contact | 05.05.2014 | 01.01.2017 | |
| Bank Sarasin & Cie AG (Broker) | Analyst-Equity | - | 01.05.2007 |
| Julius Baer Holding AG | Corporate Officer/Principal | 01.01.2000 | 01.01.2005 |
| Bank Vontobel AG (Research Firm) | Analyst-Equity | - | - |
Ausbildung von Andrew C. Weiss
| University of Zurich | Graduate Degree |
Statistik
International
| Schweiz | 7 |
Operativ
| Analyst-Equity | 2 |
| Investor Relations Contact | 2 |
| Public Communications Contact | 2 |
Sektoral
| Finance | 4 |
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IDORSIA LTD | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Actelion Ltd.
 Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
| Bank Vontobel AG (Research Firm) | Finance |
| Bank Sarasin & Cie AG (Broker) | Finance |
| Julius Baer Holding AG | Finance |
- Börse
- Insiders
- Andrew C. Weiss
- Erfahrung
